跳至主要内容
临床试验/JPRN-UMIN000031896
JPRN-UMIN000031896招募中2 期

A randomized phase IIb study comparing levetiracetam alone with lacosamide add-on for reduction of epileptic seizure after brain tumor surgery - CLEAR-EPI study

Department of Neurosurgery, University of Tsukuba0 个研究点目标入组 235 人开始时间: 2018年3月30日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
235

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 99years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) a patient who has a past-history of severe adverse effect due to LEV, PHT, fPHT or LCM 2) a patient who is treated with intra-venous LEV, fPHT or LCM 3) a patient who is treated with oral PHT or LCM

研究者

发起方
Department of Neurosurgery, University of Tsukuba

相似试验